Angiodynamics (ANGO) Net Cash Flow (2010 - 2026)

Angiodynamics' Net Cash Flow history runs 17 years deep, the most recent figure standing at $16.1 million for Q2 2026.

• Quarterly Net Cash Flow rose 54.29% year-over-year to $16.1 million in Q2 2026, while the trailing twelve-month figure through May 2026 was -$2.3 million (up 88.83% YoY) and the FY2026 annual result came in at -$2.3 million, up 88.83% from the prior year.
• Net Cash Flow was $16.1 million for Q2 2026 at Angiodynamics, up from -$4.0 million in the prior quarter.
• Across five years, Net Cash Flow topped out at $17.6 million in Q1 2024 and bottomed at -$21.2 million in Q3 2024.
• A 5-year average of $1.1 million and a median of $1.6 million in 2023 frame the typical range for Net Cash Flow.
• Peak annual rise in Net Cash Flow reached 10549.7% in 2024, while the deepest fall reached 263.41% in 2024.
• Angiodynamics' Net Cash Flow stood at $5.1 million in 2022, then tumbled by 38.88% to $3.1 million in 2023, then slumped by 119.58% to -$611000.0 in 2024, then soared by 582.49% to $2.9 million in 2025, then surged by 445.25% to $16.1 million in 2026.
• Business Quant data shows ANGO's Net Cash Flow at $16.1 million in Q2 2026, -$4.0 million in Q1 2026, and $2.9 million in Q4 2025.